{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:39:59Z","timestamp":1791092399104,"version":"4.1.0"},"reference-count":47,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"DOI":"10.1210\/jc.2013-2049","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T02:58:50Z","timestamp":1387508330000},"page":"915-922","source":"Crossref","is-referenced-by-count":25,"title":["Displacement of Cortisol From Human Heart by Acute Administration of a Mineralocorticoid Receptor Antagonist"],"prefix":"10.1210","volume":"99","author":[{"given":"Javaid","family":"Iqbal","sequence":"first","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Andrew","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Cruden","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Kenyon","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W. F.","family":"Hadoke","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Walker","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113370298100_B1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113370298100_B2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113370298100_B3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113370298100_B4","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jacc.2011.04.049","article-title":"Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy","volume":"58","author":"Rossignol","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041113370298100_B5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t2019041113370298100_B6","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113370298100_B7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/eurheartj\/ehr176","article-title":"Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure","volume":"33","author":"Ivanes","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041113370298100_B8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/eurheartj\/ehr276","article-title":"Plasma aldosterone levels in patients with coronary artery disease without heart failure or myocardial infarction: implications for pathophsiology, prognosis, and therapy","volume":"33","author":"Pitt","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041113370298100_B9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041113370298100_B10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11 \u03b2-hydroxysteroid dehydrogenase\u2013tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113370298100_B11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","article-title":"Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 \u03b2-hydroxysteroid dehydrogenase in the human heart","volume":"92","author":"Lomb\u00e8s","year":"1995","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113370298100_B12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/jmcc.1996.0072","article-title":"High affinity NAD(+)-dependent 11 \u03b2-hydroxysteroid dehydrogenase in the human heart","volume":"28","author":"Slight","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t2019041113370298100_B13","first-page":"2519","article-title":"Steroidogenic enzyme gene expression in the human heart","volume":"85","author":"Kayes-Wandover","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113370298100_B14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/HJH.0b013e328335c381","article-title":"Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?","volume":"28","author":"Chai","year":"2010","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113370298100_B15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2337\/db11-1345","article-title":"Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo","volume":"61","author":"Hughes","year":"2012","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113370298100_B16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","article-title":"Minireview: 11\u03b2-hydroxysteroid dehydrogenase type 1\u2014a tissue-specific amplifier of glucocorticoid action","volume":"142","author":"Seckl","year":"2001","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113370298100_B17","first-page":"277","article-title":"Distinguishing the activities of 11\u03b2-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol","volume":"87","author":"Andrew","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113370298100_B18","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2337\/diabetes.53.8.2051","article-title":"Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-\u03b2 hydroxysteroid dehydrogenase (11\u03b2-HSD) type 1 pathway","volume":"53","author":"Basu","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113370298100_B19","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/diabetes.54.5.1364","article-title":"The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans","volume":"54","author":"Andrew","year":"2005","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113370298100_B20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2337\/db08-0969","article-title":"Cortisol release from adipose tissue by 11\u03b2-hydroxysteroid dehydrogenase type 1 in humans","volume":"58","author":"Stimson","year":"2009","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113370298100_B21","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.85.5.1899","article-title":"Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity","volume":"85","author":"Doucette","year":"1992","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113370298100_B22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1210\/jc.2008-2054","article-title":"Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men","volume":"94","author":"Mattsson","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113370298100_B23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.steroids.2008.12.012","article-title":"Development of a highly sensitive ELISA for aldosterone in mouse urine: validation in physiological and pathophysiological states of aldosterone excess and depletion","volume":"74","author":"Al-Dujaili","year":"2009","journal-title":"Steroids"},{"key":"key\n\t\t\t\t2019041113370298100_B24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/0002-9149(81)90323-4","article-title":"Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease","volume":"48","author":"Brown","year":"1981","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041113370298100_B25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/cvr\/19.1.27","article-title":"Coronary sinus blood flow determination by the thermodilution technique: influence of catheter position and respiration","volume":"19","author":"Bagger","year":"1985","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t2019041113370298100_B26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","article-title":"Reconsidering the roles of the mineralocorticoid receptor","volume":"53","author":"Funder","year":"2009","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113370298100_B27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2265.1989.tb01259.x","article-title":"The kidney is the major site of cortisone production in man","volume":"31","author":"Whitworth","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113370298100_B28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1210\/jcem-33-1-52","article-title":"Renal capture and oxidation of cortisol in man","volume":"33","author":"Hellman","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113370298100_B29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.1992.tb01478.x","article-title":"Mineralocorticoid excess and inhibition of 11 \u03b2-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome","volume":"37","author":"Walker","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113370298100_B30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-4362.1991.tb04794.x","article-title":"Topical canrenoic acid. Quantification of the antiandrogenic activity in the hamster flank organ","volume":"30","author":"Noto","year":"1991","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t2019041113370298100_B31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2265.1985.tb01090.x","article-title":"In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay","volume":"23","author":"Armanini","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113370298100_B32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1210\/endo-97-1-52","article-title":"Antiandrogenic effect of spirolactones: mechanism of action","volume":"97","author":"Corvol","year":"1975","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113370298100_B33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.CIR.0000048189.58449.F7","article-title":"Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels","volume":"107","author":"Caballero","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113370298100_B34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.bjp.0706302","article-title":"Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels","volume":"146","author":"G\u00f3mez","year":"2005","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t2019041113370298100_B35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0022-3565(25)32607-8","article-title":"Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase","volume":"217","author":"Finotti","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019041113370298100_B36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01478568","article-title":"Non-interaction of spironolactone medication and cortisol metabolism in man","volume":"56","author":"Abshagen","year":"1978","journal-title":"Klin Wochenschr"},{"key":"key\n\t\t\t\t2019041113370298100_B37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ahj.2010.06.049","article-title":"Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial","volume":"160","author":"Beygui","year":"2010","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2019041113370298100_B38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.CIR.103.1.72","article-title":"Aldosterone production is activated in failing ventricle in humans","volume":"103","author":"Mizuno","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113370298100_B39","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ajh.2010.148","article-title":"Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: \u201cRelevance of lipophilicity and affinity for ACE\u201d","volume":"23","author":"Ruzicka","year":"2010","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t2019041113370298100_B40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/HYPERTENSIONAHA.112.198986","article-title":"Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo","volume":"61","author":"Messaoudi","year":"2013","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113370298100_B41","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041113370298100_B42","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113370298100_B43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1476-5381.2008.00047.x","article-title":"Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease","volume":"156","author":"Hadoke","year":"2009","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t2019041113370298100_B44","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0735-1097(03)00493-5","article-title":"Left ventricular structural and functional characteristics in Cushing's syndrome","volume":"41","author":"Muiesan","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041113370298100_B45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1540-8175.2007.00572.x","article-title":"Assessment of left ventricular diastolic function and Tei index by tissue Doppler imaging in patients with Cushing's Syndrome","volume":"25","author":"Baykan","year":"2008","journal-title":"Echocardiography"},{"key":"key\n\t\t\t\t2019041113370298100_B46","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1210\/jc.2009-2112","article-title":"Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study","volume":"95","author":"Reynolds","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113370298100_B47","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.0500641102","article-title":"Preventing local regeneration of glucocorticoids by 11\u03b2-hydroxysteroid dehydrogenase type 1 enhances angiogenesis","volume":"102","author":"Small","year":"2005","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/3\/915\/11157986\/jcem0915.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:09:16Z","timestamp":1746086956000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/3\/915\/2537536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-2049","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,1]]}}}